An in silico investigation: Can melatonin serve as an adjuvant in NR1D1-linked chronotherapy for amyotrophic lateral sclerosis?

References

• Bali T, Miller TM. 2013. Management of amyotrophic lateral sclerosis. Mo Med. 110:417–421. doi:10.1016/j.pneurobio.2013.05.001.
   PubMedGoogle Scholar
• Chen S, Sayana P, Zhang X, Le W. 2013. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 8:28. doi:10.1186/1750-1326-8-28.
   PubMed Web of Science ®Google Scholar
• Fagiani F, Di Marino D, Romagnoli A, Travelli C, Voltan D, Di Cesare Mannelli L, Racchi M, Govoni S, Lanni C. 2022. Molecular regulations of circadian rhythm and implications for physiology and diseases. Signal Transduct Target Ther. 7:41. doi:10.1038/s41392-022-00899-y.
   PubMed Web of Science ®Google Scholar
• Griffin P, Dimitry JM, Sheehan PW, Lananna BV, Guo C, Robinette ML, Hayes ME, Cedeño MR, Nadarajah CJ, Ezerskiy LA, et al. 2019. Circadian clock protein Rev-erbα regulates neuroinflammation. Proc Natl Acad Sci USA. 116:5102–5107. doi:10.1073/pnas.1812405116.
   PubMed Web of Science ®Google Scholar
• Gulino R. 2023. Synaptic dysfunction and plasticity in amyotrophic lateral sclerosis. Int J Mol Sci. 24:4613. doi:10.3390/ijms24054613.
   PubMed Web of Science ®Google Scholar
• Guo DK, Zhu Y, Sun HY, Xu XY, Zhang S, Hao ZB, Wang GH, Mu CC, Ren HG. 2019. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway. Acta Pharmacol Sin. 40:26–34. doi:10.1038/s41401-018-0064-0.
   PubMed Web of Science ®Google Scholar
• Killoy KM, Pehar M, Harlan BA, Vargas MR. 2021. Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model. FASEB J. 35:e21343. doi:10.1096/fj.202000386RR.
   PubMed Web of Science ®Google Scholar
• Kim YH, Lazar MA. 2020. Transcriptional control of circadian rhythms and metabolism: a matter of time and space. Endocr Rev. 41:707–732. doi:10.1210/endrev/bnaa014.
   PubMed Web of Science ®Google Scholar
• Kou L, Chi X, Sun Y, Han C, Wan F, Hu J, Yin S, Wu J, Li Y, Zhou Q, et al. 2022. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome. J Neuroinflammation. 19:133.
   PubMed Web of Science ®Google Scholar
• Le Gall L, Anakor E, Connolly O, Vijayakumar UG, Duddy WJ, Duguez S. 2020. Molecular and cellular mechanisms affected in ALS. J Pers Med. 10:101. doi:10.3390/jpm10030101.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhu Y, Gao Y, Qi D, Zhao L, Zhao L, Liu C, Tao T, Zhou C, Sun X, et al. 2020. NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Cell Death Dis. 11:129. doi:10.1038/s41419-020-2314-6.
   PubMed Web of Science ®Google Scholar
• Lustoza Rodrigues TCM, de Sousa NF, Dos Santos AMF, Aires Guimarães RD, Scotti MT, Scotti L. 2023. Challenges and discoveries in polypharmacology of neurodegenerative diseases. Curr Top Med Chem. 23:349–370. doi:10.2174/1568026623666230126112628.
   PubMed Web of Science ®Google Scholar
• Meléndez-Fernández OH, Liu JA, Nelson RJ. 2023. Circadian rhythms disrupted by light at night and mistimed food intake alter hormonal rhythms and metabolism. Int J Mol Sci. 24:3392. doi:10.3390/ijms24043392.
   PubMed Web of Science ®Google Scholar
• Morvaridzadeh M, Sadeghi E, Agah S, Nachvak SM, Fazelian S, Moradi F, Persad E, Heshmati J. 2020. Effect of melatonin supplementation on oxidative stress parameters: a systematic review and meta-analysis. Pharmacol Res. 161:105210. doi:10.1016/j.phrs.2020.105210.
   PubMed Web of Science ®Google Scholar
• Murray MH, Valfort AC, Koelblen T, Ronin C, Ciesielski F, Chatterjee A, Veerakanellore GB, Elgendy B, Walker JK, Hegazy L, et al. 2022. Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB. Nat Commun. 13:7131. doi:10.1038/s41467-022-34892-4.
   PubMed Web of Science ®Google Scholar
• Neupane P, Thada PK, Singh P, Faisal AR, Rai N, Poudel P, Waleed MS, Quinonez J, Ruxmohan S, Jain E. 2023. Investigating Edaravone use for management of amyotrophic lateral sclerosis (ALS): a narrative review. Cureus. 15:e33746. doi:10.7759/cureus.33746.
   PubMed Web of Science ®Google Scholar
• Pourcet B, Zecchin M, Ferri L, Beauchamp J, Sitaula S, Billon C, Delhaye S, Vanhoutte J, Mayeuf-Louchart A, Thorel Q, et al. 2018. Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice. Gastroenterology. 154:1449–1464.e20. doi:10.1053/j.gastro.2017.12.019.
   PubMed Web of Science ®Google Scholar
• Rastelli G, Del Rio A, Degliesposti G, Sgobba M. 2010. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem. 31:797–810. doi:10.1002/jcc.21372.
   PubMed Web of Science ®Google Scholar
• Serin Y, Tek NA. 2019. Effect of circadian rhythm on metabolic processes and the regulation of energy balance. Ann Nutr Metab. 74:322–330. doi:10.1159/000500071.
   PubMed Web of Science ®Google Scholar
• Sierk ML, Zhao Q, Rastinejad F. 2001. DNA deformability as a recognition feature in the reverb response element. Biochemistry. 40:12833–12843. doi:10.1021/bi011086r.
   PubMed Web of Science ®Google Scholar
• Soares P, Silva C, Chavarria D, Silva FSG, Oliveira PJ, Borges F. 2023. Drug discovery and amyotrophic lateral sclerosis: emerging challenges and therapeutic opportunities. Ageing Res Rev. 83:101790. doi:10.1016/j.arr.2022.101790.
   PubMed Web of Science ®Google Scholar
• Tarocco A, Caroccia N, Morciano G, Wieckowski MR, Ancora G, Garani G, Pinton P. 2019. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis. 10:317. doi:10.1038/s41419-019-1556-7.
   PubMed Web of Science ®Google Scholar
• Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM. 2022. Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci. 23:5954. doi:10.3390/ijms23115954.
   PubMed Web of Science ®Google Scholar
• Verma M, Lizama BN, Chu CT. 2022. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener. 11:3. doi:10.1186/s40035-021-00278-7.
   PubMed Web of Science ®Google Scholar
• Wang XL, Li L. 2021. Circadian clock regulates inflammation and the development of neurodegeneration. Front Cell Infect Microbiol. 11:696554. doi:10.3389/fcimb.2021.696554.
   PubMed Web of Science ®Google Scholar
• Wolff SEC, Wang XL, Jiao H, Sun J, Kalsbeek A, Yi CX, Gao Y. 2020. The Effect of Rev-erbα agonist SR9011 on the immune response and Cell metabolism of microglia. Front Immunol. 11:550145. doi:10.3389/fimmu.2020.550145.
   PubMed Web of Science ®Google Scholar
• Yıldırım Z, Toktaş DN, Demir Ö, Gül Z, Şen Utsukarçi B. 2023. Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi Yaklaşımları. HUJPHARM. 43:50–69. doi:10.52794/hujpharm.1064372.
   Google Scholar